| Symbol | MDXG |
|---|---|
| Name | MIMEDX GROUP, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 1775 W OAK COMMONS COURT, NE, MARIETTA, GA 30062 |
| Telephone | (770) 651-9100 |
| Fax | — |
| — | |
| Website | https://www.mimedx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001376339 |
| Description | MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedxs key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties. Additional info from NASDAQ: |
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
Read moreNew Form DEFA14A - MIMEDX GROUP, INC. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001376339-26-000037 <b>Size:</b> 2 MB
Read moreNew Form DEF 14A - MIMEDX GROUP, INC. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001376339-26-000033 <b>Size:</b> 5 MB
Read moreMIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07173621 | Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Ope… | Na | Thyroid; Wound | Enrolling_By_Invitation | 2025-10-01 | 2027-10-01 | ClinicalTrials.gov |
| NCT06600724 | Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Trea… | Na | Diabetic Foot Ulcer | Recruiting | 2024-08-27 | 2026-08-01 | ClinicalTrials.gov |
| NCT06236750 | Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM)… | Na | Diabetic Foot Ulcer | Recruiting | 2023-08-04 | 2027-01-01 | ClinicalTrials.gov |
| NCT05796765 | Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis | Phase2 | Knee Osteoarthritis | Terminated | 2023-03-24 | 2023-12-15 | ClinicalTrials.gov |
| NCT03485157 | Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee | Phase2 | Knee Osteoarthritis | Completed | 2018-03-27 | 2022-04-19 | ClinicalTrials.gov |
| NCT03479463 | Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy | — | Larynx Cancer | Terminated | 2018-03-19 | 2019-03-30 | ClinicalTrials.gov |
| NCT03479489 | Use of Human Dehydrated Amnion Chorion Allograft in Closed Hemorroidectomy | Na | External Hemorrhoid | Completed | 2018-02-05 | 2018-12-30 | ClinicalTrials.gov |
| NCT03414255 | Micronized dHACM Injectable for the Treatment of Achille Tendonitis | Phase3 | Tendonitis;Achilles | Completed | 2018-01-09 | 2021-03-30 | ClinicalTrials.gov |
| NCT03414268 | Micronized dHACM Injectable for the Treatment of Plantar Fasciitis | Phase3 | Fasciitis, Plantar | Completed | 2018-01-08 | 2021-03-17 | ClinicalTrials.gov |
| NCT03529578 | A Single Center, Prospective, Case Series of the Treatment of Pressure Ulcers a… | Na | Pressure Ulcer | Completed | 2017-06-06 | 2019-06-01 | ClinicalTrials.gov |
| NCT03323021 | Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy | Na | Partial Nephrectomy | Completed | 2017-05-23 | 2019-02-21 | ClinicalTrials.gov |
| NCT03084068 | Use of Human Dehydrated Umbilical Cord Allograft in Supraspinatus Tendon Repair | Na | Shoulder Injury | Completed | 2017-02-01 | 2019-01-17 | ClinicalTrials.gov |
| NCT03074526 | Protocol for the Clinical Evaluation of Lyophilized Amniotic Fluid in the Treat… | Na | Osteoarthritis, Knee | Completed | 2017-01-23 | 2018-04-25 | ClinicalTrials.gov |
| NCT02645591 | Randomized AmnioFix Study During Radical Prostatectomy | Phase2 | Prostate Cancer | Withdrawn | 2016-11-01 | — | ClinicalTrials.gov |
| NCT02844660 | Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ul… | Na | Diabetic Foot Ulcers | Completed | 2016-07-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT02861560 | Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers | Na | Pressure Ulcer | Completed | 2016-05-01 | 2018-05-01 | ClinicalTrials.gov |
| NCT02765737 | Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment o… | Na | Treatment of Partial Thickness Burns | Terminated | 2016-04-01 | 2019-01-01 | ClinicalTrials.gov |
| NCT02768155 | Evaluation of Amniotic Fluid Product in Knee Osteoarthritis | Na | Osteoarthritis of the Knee | Completed | 2016-04-01 | 2017-07-01 | ClinicalTrials.gov |
| NCT02526173 | DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP) | Na | Erectile Dysfunction | Completed | 2015-10-01 | 2018-06-21 | ClinicalTrials.gov |
| NCT02587104 | dHACM In the Treatment of Diabetic Foot Ulcers | Na | Diabetic Foot Ulcers | Completed | 2015-06-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02589210 | dHACM Mesh In the Treatment of Diabetic Foot Ulcers | Na | Diabetic Foot Ulcers | Completed | 2015-05-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT02427191 | Micronized dHACM Injectable for the Treatment of Plantar Fasciitis | Phase2 | Fasciitis, Plantar | Completed | 2015-03-31 | 2018-08-01 | ClinicalTrials.gov |
| NCT02300909 | dHACM in Lumbar Decompression and Microdiscectomy Surgery | Na | Scarring | Completed | 2014-11-01 | 2018-06-01 | ClinicalTrials.gov |
| NCT02033824 | Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring | Na | Scarring | Completed | 2014-04-01 | 2018-06-01 | ClinicalTrials.gov |
| NCT02011503 | Use of dHACM in the Treatment of Venous Leg Ulcers | Na | Leg Ulcer | Completed | 2014-03-01 | 2017-11-30 | ClinicalTrials.gov |
| NCT02088567 | Amniotic Membrane in Total Knee Replacements to Reduce Scarring | Na | Scarring | Completed | 2014-01-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01996111 | Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the T… | Na | Plantar Fasciitis | Terminated | 2013-09-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01995604 | Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionate… | Na | Scarring | Withdrawn | 2013-09-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01921491 | DHACM vs Other Commercially Available Treatments | Na | Diabetic Foot Ulcer | Completed | 2013-08-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01921569 | Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of La… | Na | Epicondylitis, Lateral Humeral | Terminated | 2013-06-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01832168 | Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparosco… | Na | Pudendal Nerve | Completed | 2013-02-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01657474 | Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft … | Na | Diabetic Foot Ulcer | Completed | 2012-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01659827 | Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitr… | Na | Plantar Fasciitis | Completed | 2012-09-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01693133 | Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of … | Na | Diabetic Foot Ulcer | Completed | 2012-07-01 | 2018-06-01 | ClinicalTrials.gov |
| NCT01552447 | Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care A… | Na | Venous Leg Ulcer | Completed | 2012-03-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01552499 | Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabeti… | Na | Diabetic Foot Ulcer | Completed | 2012-03-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01357187 | An Evaluation of the Effect of the AmnioFix Amniotic Membrane Allograft in Pati… | Na | Adhesions of Soft Tissue | Completed | 2011-09-01 | 2014-05-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Saline Placebo | Other | Approved | Osteoarthritis, Knee | COMPLETED | NCT03074526 |
| Amniotic Fluid | Other | Approved | Osteoarthritis, Knee | COMPLETED | NCT03074526 |
| Saline | Other | Approved | Plantar Fasciitis | COMPLETED | NCT01659827 |
| 1.25cc AmnioFix | Other | Approved | Plantar Fasciitis | COMPLETED | NCT01659827 |
| 0.5cc AmnioFix | Other | Approved | Plantar Fasciitis | COMPLETED | NCT01659827 |
| Marcaine | Other | Approved | Plantar Fasciitis | COMPLETED | NCT01659827 |
| Biweekly application of EpiFix plus standard of care | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01657474 |
| Weekly application of EpiFix plus standard of care | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01657474 |
| Injection of 1.0 cc of 40 mg/ml micrograft dHACM suspension | Other | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension | Other | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension | Other | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Injection of 1.0 cc of 0.9% Saline | Other | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Application of dHACM | Other | Approved | Scarring | WITHDRAWN | NCT01995604 |
| Application of Sterile 0.9% Saline Solution | Other | Approved | Scarring | WITHDRAWN | NCT01995604 |
| Application of dehydrated human amniotic membrane | Other | Approved | Pudendal Nerve | COMPLETED | NCT01832168 |
| Application of Absorbable Hemostat | Other | Approved | Pudendal Nerve | COMPLETED | NCT01832168 |
| Robotic Assisted Laparoscopic Prostatectomy | Other | Approved | Pudendal Nerve | COMPLETED | NCT01832168 |
| Scheduled removal of posterior instrumentation without AmnioFix | Device | Approved | Adhesions of Soft Tissue | COMPLETED | NCT01357187 |
| Scheduled removal of posterior instrumentation with AmnioFix | Device | Approved | Adhesions of Soft Tissue | COMPLETED | NCT01357187 |
| Applications of EpiFix | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01552499 |
| Standard of care | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01552499 |
| Application of dHACM | Other | Approved | Scarring | COMPLETED | NCT02088567 |
| Total Knee Arthroplasty | Other | Approved | Scarring | COMPLETED | NCT02088567 |
| Normal Saline Injection | Other | Approved | Epicondylitis, Lateral Humeral | TERMINATED | NCT01921569 |
| dHACM Injection | Other | Approved | Epicondylitis, Lateral Humeral | TERMINATED | NCT01921569 |
| Standard of Care Therapy | Drug | Approved | Epicondylitis, Lateral Humeral | TERMINATED | NCT01921569 |
| Compression Therapy | Drug | Approved | Venous Leg Ulcer | COMPLETED | NCT01552447 |
| EpiFix | Other | Approved | Venous Leg Ulcer | COMPLETED | NCT01552447 |
| Questionnaire | Other | Phase PHASE2 | Prostate Cancer | WITHDRAWN | NCT02645591 |
| AmnioFix® | Other | Phase PHASE2 | Prostate Cancer | WITHDRAWN | NCT02645591 |
| Robotic Assisted Laparoscopic Radical Prostatectomy (RARP) | Other | Phase PHASE2 | Prostate Cancer | WITHDRAWN | NCT02645591 |
| EpiFix Mesh | Other | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02589210 |
| EpiFix | Other | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02587104 |
| Placebo Control | Other | Approved | Osteoarthritis of the Knee | COMPLETED | NCT02768155 |
| Amniotic Fluid 2.0ml dose | Other | Approved | Osteoarthritis of the Knee | COMPLETED | NCT02768155 |
| Amniotic Fluid 4.0ml dose | Other | Approved | Osteoarthritis of the Knee | COMPLETED | NCT02768155 |
| Dehydrated Human Amnion/Chorion Membrane (dHACM) | Other | Approved | Scarring | COMPLETED | NCT02300909 |
| Microdiscectomy Surgery | Procedure | Approved | Scarring | COMPLETED | NCT02300909 |
| Lumbar Decompression Surgery | Procedure | Approved | Scarring | COMPLETED | NCT02300909 |
| Craniectomy | Other | Approved | Scarring | COMPLETED | NCT02033824 |
| dHACM | Other | Approved | Scarring | COMPLETED | NCT02033824 |
| dHACM | Other | Approved | Pressure Ulcer | COMPLETED | NCT02861560 |
| Application of dHACM | Other | Approved | Leg Ulcer | COMPLETED | NCT02011503 |
| Multi-layer compression therapy | Drug | Approved | Leg Ulcer | COMPLETED | NCT02011503 |
| EpiFix plus Standard of Care | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01693133 |
| Standard of Care: Moist Wound Therapy and Offloading | Drug | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01693133 |
| dHACM Application | Other | Approved | Erectile Dysfunction | COMPLETED | NCT02526173 |
| RALP using full nerve sparing technique | Other | Approved | Erectile Dysfunction | COMPLETED | NCT02526173 |
| Human dehydrated amnion chorion allograft | Other | Approved | External Hemorrhoid | COMPLETED | NCT03479489 |
| Placebo | Other | Approved | Shoulder Injury | COMPLETED | NCT03084068 |
| Human dehydrated umbilical cord allograft | Other | Approved | Shoulder Injury | COMPLETED | NCT03084068 |
| Offloading | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01921491 |
| Dressing Application | Other | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01921491 |
| dHACM | Other | Approved | Pressure Ulcer | COMPLETED | NCT03529578 |
| Dehydrated human amnion/chorion membrane | Other | Preclinical | Larynx Cancer | TERMINATED | NCT03479463 |
| Standard of Care | Other | Approved | Partial Nephrectomy | COMPLETED | NCT03323021 |
| Dehydrated human amnion/chorion membrane | Other | Approved | Partial Nephrectomy | COMPLETED | NCT03323021 |
| Saline Injection | Other | Phase PHASE2 | Fasciitis, Plantar | COMPLETED | NCT02427191 |
| AmnioFix® Injectable | Other | Phase PHASE2 | Fasciitis, Plantar | COMPLETED | NCT02427191 |
| Standard of Care | Other | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02844660 |
| EpiCord | Other | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02844660 |
| Mepilex Ag | Other | Approved | Treatment of Partial Thickness Burns | TERMINATED | NCT02765737 |
| Dehydrated Human Amnion/Chorion Membrane | Other | Approved | Treatment of Partial Thickness Burns | TERMINATED | NCT02765737 |
| Saline Injection | Other | Phase PHASE3 | Fasciitis, Plantar | COMPLETED | NCT03414268 |
| Micronized dHACM | Other | Phase PHASE3 | Fasciitis, Plantar | COMPLETED | NCT03414268 |
| Saline Injection | Other | Phase PHASE3 | Tendonitis;Achilles | COMPLETED | NCT03414255 |
| Micronized DHACM | Other | Phase PHASE3 | Tendonitis;Achilles | COMPLETED | NCT03414255 |
| Saline | Other | Phase PHASE2 | Knee Osteoarthritis | COMPLETED | NCT03485157 |
| Micronized dHACM | Other | Phase PHASE2 | Knee Osteoarthritis | COMPLETED | NCT03485157 |
| Saline | Other | Phase PHASE2 | Knee Osteoarthritis | TERMINATED | NCT05796765 |
| Micronized DHACM 100 mg | Other | Phase PHASE2 | Knee Osteoarthritis | TERMINATED | NCT05796765 |
| Micronized DHACM 40 mg | Other | Phase PHASE2 | Knee Osteoarthritis | TERMINATED | NCT05796765 |
| EPIFIX | Other | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06236750 |
| EPIXPRESS | Other | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06600724 |
| EPIEFFECT | Other | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06600724 |
| Standard of Care | Other | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06600724 |
| Amnioeffect | Other | Approved | Thyroid; Wound | ENROLLING_BY_INVITATION | NCT07173621 |
| Amnioeffect | OTHER | Approved | Thyroid; Wound | ENROLLING_BY_INVITATION | NCT07173621 |
| EPIXPRESS | OTHER | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06600724 |
| EPIEFFECT | OTHER | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06600724 |
| EPIFIX | DEVICE | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06236750 |
| Micronized DHACM 100 mg | BIOLOGICAL | Phase PHASE2 | Knee Osteoarthritis | TERMINATED | NCT05796765 |
| Micronized DHACM 40 mg | BIOLOGICAL | Phase PHASE2 | Knee Osteoarthritis | TERMINATED | NCT05796765 |
| Human dehydrated amnion chorion allograft | OTHER | Approved | External Hemorrhoid | COMPLETED | NCT03479489 |
| Micronized dHACM | BIOLOGICAL | Phase PHASE2 | Knee Osteoarthritis | COMPLETED | NCT03485157 |
| Micronized DHACM | BIOLOGICAL | Phase PHASE3 | Tendonitis;Achilles | COMPLETED | NCT03414255 |
| Dehydrated human amnion/chorion membrane | BIOLOGICAL | Preclinical | Larynx Cancer | TERMINATED | NCT03479463 |
| Placebo | OTHER | Approved | Shoulder Injury | COMPLETED | NCT03084068 |
| Human dehydrated umbilical cord allograft | OTHER | Approved | Shoulder Injury | COMPLETED | NCT03084068 |
| Saline Placebo | OTHER | Approved | Osteoarthritis, Knee | COMPLETED | NCT03074526 |
| Amniotic Fluid | OTHER | Approved | Osteoarthritis, Knee | COMPLETED | NCT03074526 |
| Standard of Care | OTHER | Approved | Diabetic Foot Ulcer | RECRUITING | NCT06600724 |
| EpiCord | BIOLOGICAL | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02844660 |
| Placebo Control | OTHER | Approved | Osteoarthritis of the Knee | COMPLETED | NCT02768155 |
| Amniotic Fluid 2.0ml dose | OTHER | Approved | Osteoarthritis of the Knee | COMPLETED | NCT02768155 |
| Amniotic Fluid 4.0ml dose | OTHER | Approved | Osteoarthritis of the Knee | COMPLETED | NCT02768155 |
| Mepilex Ag | DEVICE | Approved | Treatment of Partial Thickness Burns | TERMINATED | NCT02765737 |
| Dehydrated Human Amnion/Chorion Membrane | OTHER | Approved | Treatment of Partial Thickness Burns | TERMINATED | NCT02765737 |
| Questionnaire | BEHAVIORAL | Phase PHASE2 | Prostate Cancer | WITHDRAWN | NCT02645591 |
| AmnioFix® | BIOLOGICAL | Phase PHASE2 | Prostate Cancer | WITHDRAWN | NCT02645591 |
| Robotic Assisted Laparoscopic Radical Prostatectomy (RARP) | PROCEDURE | Phase PHASE2 | Prostate Cancer | WITHDRAWN | NCT02645591 |
| EpiFix Mesh | OTHER | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02589210 |
| dHACM Application | OTHER | Approved | Erectile Dysfunction | COMPLETED | NCT02526173 |
| RALP using full nerve sparing technique | PROCEDURE | Approved | Erectile Dysfunction | COMPLETED | NCT02526173 |
| Saline Injection | DRUG | Phase PHASE3 | Fasciitis, Plantar | COMPLETED | NCT03414268 |
| AmnioFix® Injectable | OTHER | Phase PHASE2 | Fasciitis, Plantar | COMPLETED | NCT02427191 |
| Dehydrated Human Amnion/Chorion Membrane (dHACM) | OTHER | Approved | Scarring | COMPLETED | NCT02300909 |
| Microdiscectomy Surgery | PROCEDURE | Approved | Scarring | COMPLETED | NCT02300909 |
| Lumbar Decompression Surgery | PROCEDURE | Approved | Scarring | COMPLETED | NCT02300909 |
| Craniectomy | PROCEDURE | Approved | Scarring | COMPLETED | NCT02033824 |
| dHACM | PROCEDURE | Approved | Pressure Ulcer | COMPLETED | NCT03529578 |
| Normal Saline Injection | OTHER | Approved | Epicondylitis, Lateral Humeral | TERMINATED | NCT01921569 |
| dHACM Injection | OTHER | Approved | Epicondylitis, Lateral Humeral | TERMINATED | NCT01921569 |
| Standard of Care Therapy | BEHAVIORAL | Approved | Epicondylitis, Lateral Humeral | TERMINATED | NCT01921569 |
| Offloading | DEVICE | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01921491 |
| Dressing Application | PROCEDURE | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01921491 |
| Total Knee Arthroplasty | PROCEDURE | Approved | Scarring | COMPLETED | NCT02088567 |
| Multi-layer compression therapy | PROCEDURE | Approved | Leg Ulcer | COMPLETED | NCT02011503 |
| Injection of 1.0 cc of 40 mg/ml micrograft dHACM suspension | PROCEDURE | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Injection of 1.0 cc of 20 mg/ml micrograft dHACM suspension | PROCEDURE | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Injection of 1.0 cc of 10 mg/ml micrograft dHACM suspension | PROCEDURE | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Injection of 1.0 cc of 0.9% Saline | PROCEDURE | Approved | Plantar Fasciitis | TERMINATED | NCT01996111 |
| Application of dHACM | OTHER | Approved | Scarring | COMPLETED | NCT02088567 |
| Application of Sterile 0.9% Saline Solution | OTHER | Approved | Scarring | WITHDRAWN | NCT01995604 |
| Application of dehydrated human amniotic membrane | OTHER | Approved | Pudendal Nerve | COMPLETED | NCT01832168 |
| Application of Absorbable Hemostat | OTHER | Approved | Pudendal Nerve | COMPLETED | NCT01832168 |
| Robotic Assisted Laparoscopic Prostatectomy | PROCEDURE | Approved | Pudendal Nerve | COMPLETED | NCT01832168 |
| EpiFix plus Standard of Care | OTHER | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01693133 |
| Standard of Care: Moist Wound Therapy and Offloading | OTHER | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01693133 |
| Saline | DRUG | Phase PHASE2 | Knee Osteoarthritis | TERMINATED | NCT05796765 |
| 1.25cc AmnioFix | OTHER | Approved | Plantar Fasciitis | COMPLETED | NCT01659827 |
| 0.5cc AmnioFix | OTHER | Approved | Plantar Fasciitis | COMPLETED | NCT01659827 |
| Marcaine | OTHER | Approved | Plantar Fasciitis | COMPLETED | NCT01659827 |
| Biweekly application of EpiFix plus standard of care | OTHER | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01657474 |
| Weekly application of EpiFix plus standard of care | OTHER | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01657474 |
| Applications of EpiFix | OTHER | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01552499 |
| Standard of care | OTHER | Approved | Diabetic Foot Ulcer | COMPLETED | NCT01552499 |
| Compression Therapy | OTHER | Approved | Venous Leg Ulcer | COMPLETED | NCT01552447 |
| EpiFix | OTHER | Approved | Diabetic Foot Ulcers | COMPLETED | NCT02587104 |
| Scheduled removal of posterior instrumentation without AmnioFix | OTHER | Approved | Adhesions of Soft Tissue | COMPLETED | NCT01357187 |
| Scheduled removal of posterior instrumentation with AmnioFix | OTHER | Approved | Adhesions of Soft Tissue | COMPLETED | NCT01357187 |